Regulations.gov document
Exhibit 1- A pilot study assessing the bioavailability and pharmacokinetics of diazepam…
Supporting & Related Material · FDA-2019-P-4832 · posted Oct 17, 2019
Key facts
| Document ID | FDA-2019-P-4832-0003 |
|---|---|
| Title | Exhibit 1- A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers re: Citizen Petition from Arent Fox LLP on behalf of Aquestive Therapeutics, Inc |
| Document type | Supporting & Related Material |
| Agency | FDA |
| Docket | FDA-2019-P-4832 |
| Posted | Oct 17, 2019 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: